DGPPN 2018 Programm

POSTER PRESENTATIONS 304 WEDNESDAY THURSDAY FRIDAY SATURDAY › Thursday, 29 Nov 2018 P-21 (e) Poster Presentation 13:30– 15:00 h | Hall Helsinki 1 /2 TOPIC 1: Neurocognitive disorders, organic mental disorders, dementia, F0 Neurocognitive disorders, organic men- tal disorders, dementia Chair: Andreas Fellgiebel, Mainz (Germany) 001 Aducanumab titration dosing regi- men: 24-month analysis from PRIME, a randomized, double-blind, placebo-con- trolled Phase 1b study in patients with prodromal or mild Alzheimer's disease Philipp von Rosenstiel, Cambridge (USA) Sarah Gheuens, Tianle Chen, John O'Gorman, Ping Chiao, Christian von Hehn, LeAnne Skordos, Roger Nitsch, Samantha Budd Haeberlein, Alfred Sandrock 002 24-month amyloid PET results of the gantenerumab high-dose open label extension studies Timo Grimmer, Munich (Germany) Gregory Klein, Paul Delmar, Carsten Hofmann, Danielle Abi-Saab, Mirjana Andjelkovic, Smiljana Ristic, Nicola Voyle, John Seibyl, Ken Marek, Ferenc Martenyi, Monika Baudler, Paulo Fontoura, Rachelle Doody 003 The effect of low doses of gan- tenerumab on amyloid and tau biomark- ers in cerebrospinal fluid (CSF) in the Marguerite RoAD study Christine von Arnim, Ulm (Germany) Nicola Voyle, Danielle Abi-Saab, Gregory Klein, Carsten Hofmann, Paul Delmar, Nathalie Pross, Mirjana Andjelkovic, Smiljana Ristic, Ferenc Martenyi, Paulo Fontoura, Rachelle Doody 004 Baseline characteristics from phase 3 trials of crenezumab in prodromal to mild Alzheimer's disease (CRED) Oliver Peters, Berlin (Germany) Helen Lin, Susanne Ostrowitzki, Kaycee M. Sink, Laurie Millar, Francis Warren, Jillian Smith, Andres Schneider, Reina N. Fuji, Angelica Quartino, Howard Mackey, Michael Rabbia, Susan Yule, Rachelle Doody 005 A unified pre-analytical protocol for handling of CSF samples before analyses of AD biomarker levels Manfred Uhr, Munich (Germany) Oskar Hansson, Richard Batrla-Utermann, Ekaterina Bauer, Nadja Baur-Kolarov, Britta Brix, Maria C Carrillo, Veronika Corradini, Robert Dean, Udo Eichenlaub, Christina Hall, James Hendrix, John Lawson, Valeria Lifke, José Luis Molineuvo, Sandra Rutz, Salvatore Salamone, Christopher Traynham, Robert Umek, Simone Wahl, Hugo Vanderstichele, Manu Vandijck, Kai Blennow 006 Predicting future dementia: the role of white-matter integrity Theresa Müller, Cologne (Germany) Nicola M. Payton, Grégoria Kalpouzos, Martin Lövdén, Laura Fratiglioni, Lars Bäckman, Erika Jonsson Laukka 007 Predicting verbal episodic memory changes with measures of brain atrophy: a longitudinal approach in patients with mild cognitive impairment Katharina Klink, Bern (Switzerland) Ahmed Abdulkadir, Lora Minkova, Michel Grothe, Stefan Teipel, Lena Schumacher, Christoph Kaller, Jacob Lahr, Stefan Klöppel, Jessica Peter 008 Connectome genetics reveal neuro- psychiatric brain phenotypes in thyroid hormone transporter deficiency Jonathan Reinwald, Mannheim (Germany) Alexander Sartorius, Wolfgang Weber-Fahr, Heike Heuer, Thomas Münte POSTER PRESENTATIONS